Valuation : genOway

Market Cap 22.87M 26.59M 21.51M 19.63M 36.72M 2.51B 36.84M 255M 98.57M 1.29B 99.85M 97.67M 4.1B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.58M 34.4M 27.82M 25.4M 47.5M 3.25B 47.66M 330M 128M 1.67B 129M 126M 5.31B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 month-1.20%
3 months+1.22%
6 months+8.30%
Current year-8.49%
1 week 2.46
Extreme 2.46
2.53
1 month 2.4
Extreme 2.4
2.58
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-9.16%-32.97% 26.57M
-1.16%-2.77%-2.91%+13.85% 48.93B
-0.40%+2.16%+418.57%+554.47% 45.01B
-1.42%+2.52%+42.67%+22.27% 44.07B
-1.22%-0.37%+4.82%+84.42% 40.73B
-0.96%-1.38%+15.75%+45.91% 33.52B
-0.21%+2.86% - - 17.77B
-0.35%-0.45%+21.42%+117.63% 16.5B
-1.54%-1.30%+12.16%+31.14% 14.67B
-1.65%+0.09%+75.93%+41.15% 13.77B
Average -0.89%+0.25%+64.36%+97.54% 27.5B
Weighted average by Cap. -1.00%-0.04%+88.95%+134.35%

Financials

2024 2025
Net sales 27.53M 32.01M 25.89M 23.64M 44.21M 3.03B 44.35M 307M 119M 1.55B 120M 118M 4.94B 28.6M 33.26M 26.9M 24.56M 45.93M 3.15B 46.07M 319M 123M 1.61B 125M 122M 5.13B
Net income 1.83M 2.13M 1.72M 1.57M 2.94M 201M 2.95M 20.42M 7.89M 103M 7.99M 7.82M 328M 928K 1.08M 873K 797K 1.49M 102M 1.49M 10.35M 4M 52.25M 4.05M 3.96M 166M
Net Debt 623K 724K 586K 535K 1M 68.51M 1M 6.95M 2.69M 35.08M 2.72M 2.66M 112M 6.72M 7.81M 6.32M 5.77M 10.79M 739M 10.82M 74.92M 28.96M 378M 29.34M 28.7M 1.21B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-09-07 €2.480 0.00% 3,010
26-09-04 €2.480 -0.80% 1,527
26-09-03 €2.500 -0.79% 1,604
26-09-02 €2.520 +2.44% 1,070
26-09-01 €2.460 -0.81% 3,938
  1. Stock Market
  2. Stocks
  3. ALGEN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!